AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...

Thanks to the incredible work of the American Heart Association, a Bham local got 20 extra years with his dad. Read his story + sign up for the Birmingham Heart Walk on March 14 at Railroad Park. 👏 N ...

Pulmonary embolism (PE) continues to challenge clinicians with its complex presentation and potential for rapid deterioration. As the third leading cause of cardiovascular mortality in the U.S.

The 2025 AHA/ACC High Blood Pressure Guideline reflects the latest recommendations and advancements in hypertension research and clinical practice. This curated collection of commentaries and ...

About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...

Abstract: This research explores the integration of artificial intelligence (AI) in cardiovascular medicine, highlighting its potential to revolutionize the diagnosis, treatment, and management of ...